Josh Lehrer, M.D., M.Phil., FACC
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Josh Lehrer, M.D., M.Phil., FACC
Josh Lehrer, M.D., M.Phil., FACC is recorded as COO at Lisata Therapeutics, Inc. (LSTA). Lisata Therapeutics, Inc. reported in an 8-K filed September 17, 2026 that Josh Lehrer, M.D., M.Phil., FACC was appointed President and Chief Operating Officer, effective September 17, 2026.
“In accordance with the Merger Agreement, on September 17, 2026, effective immediately after the First Effective Time, Josh Lehrer, M.D., M.Phil., FACC was appointed as the President and Chief Operating Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-17–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lisata Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Mazzo CEO
- David J. Mazzo, Ph.D. CEO
- David Mazzo CEO, Board Member
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
- Anne Whitaker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.